Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review
Year: 2025
Type: review
Abstract: This review examines the effectiveness of various surgical and endoscopic bariatric interventions in improving several components of metabolic dysfunction-associated steatotic liver disease (MASLD). Roux-en-Y gastric bypass (RYGB) consistently showed substantial long-term reductions in liver fat, inflammation, and fibrosis, achieving resolution of steatosis in up to 95% of cases. Vertical sleeve gastrectomy (VSG) provided comparable hepatic benefits, significantly reducing liver fibrosis and steatosis in approximately 60% of patients. Adjustable gastric banding (AGB) demonstrated meaningful though comparatively modest hepatic improvements, with steatosis resolution in about 42% of patients. More aggressive procedures like biliopancreatic diversion with duodenal switch (BPD-DS) showed profound metabolic effects, though with increased nutritional risk. Endoscopic therapies, including intragastric balloon (IGB) and endoscopic sleeve gastroplasty (ESG), offered notable short- to medium-term hepatic improvements, significantly reducing steatosis and fibrosis markers. Newer therapies like duodenal mucosal resurfacing (DMR) and the duodenal-jejunal bypass liner showed promising preliminary results, warranting further investigation. Overall, surgical interventions remain superior for sustained liver health improvements, while endoscopic therapies present viable alternatives for patients requiring less invasive interventions.
Source: Journal of Clinical Medicine
DOI: 10.3390/jcm14124012
Authors: Dana Tasabehji, Sanaz Saleh, Mohamad Mokadem
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: non-alcoholic fatty liver disease, bariatric surgery, endoscopic treatment, Roux-en-Y gastric bypass, sleeve gastrectomy, gastric banding, biliopancreatic diversion with duodenal switch, intragastric balloon, endoscopic sleeve gastroplasty, duodenal mucosal resurfacing, duodenal-jejunal bypass liner, hepatic steatosis, liver fibrosis, liver inflammation
Open Access status: gold
Estimated APC paid: $3,137
Awards: G3196387476, G4402732402
OpenAlex ID: W4411101122
